Brevan Howard Capital Management LP Ionis Pharmaceuticals Inc Transaction History
Brevan Howard Capital Management LP
- $9.23 Billion
- Q1 2025
A detailed history of Brevan Howard Capital Management LP transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 22,973 shares of IONS stock, worth $757,879. This represents 0.01% of its overall portfolio holdings.
Number of Shares
22,973
Previous 21,366
7.52%
Holding current value
$757,879
Previous $746,000
7.1%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding IONS
# of Institutions
399Shares Held
146MCall Options Held
916KPut Options Held
552K-
Vanguard Group Inc Valley Forge, PA16.4MShares$541 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.2MShares$534 Million0.32% of portfolio
-
Capital World Investors Los Angeles, CA12.4MShares$408 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$340 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.42MShares$278 Million0.05% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.68B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...